Eupraxia is a clinical-stage biotechnology company focused on developing locally delivered, extended-release products that have the potential to address therapeutic areas with high unmet medical need. DiffuSphere, a proprietary, polymer-based micro-sphere technology, is designed to facilitate targeted drug delivery of both existing and novel drugs. The technology is designed to support an extended duration of effect and delivery of drugs in a hyper-localized fashion, targeting only the tissues that physicians want to treat. We believe the potential for fewer adverse events may be achieved through the precision targeting and the stable and flat delivery of the active ingredient when using the DiffuSphere technology, versus the peaks and troughs seen with more traditional drug delivery methods. The precision of Eupraxia's DiffuSphere technology platform has the potential to augment and transform existing FDA-approved drugs to improve their safety, tolerability, efficacy and duration of effect. The potential uses in therapeutic areas may go beyond pain and inflammatory gastrointestinal disease, where Eupraxia currently is developing advanced treatments, also to be applicable in oncology, infectious disease and other critical disease areas.
Eupraxia's EP-104GI is currently in a Phase 1b/2 trial, the RESOLVE trial, for the treatment of EoE. EP-104GI is administered as an injection into the esophageal wall, providing local delivery of drug. This is a unique treatment approach for EoE. Eupraxia also recently completed a Phase 2b clinical trial (SPRINGBOARD) of EP-104IAR for the treatment of pain due to knee osteoarthritis. The trial met its primary endpoint and three of the four secondary endpoints. In addition, Eupraxia is developing a pipeline of later and earlier-stage long-acting formulations. Potential pipeline indications include candidates for other inflammatory joint indications and oncology, each designed to improve on the activity and tolerability of currently approved drugs. For further details about Eupraxia, please visit the Company's website at:
As our Clinical Research Associate (CRA) you will be primarily responsible for the operational management and oversight of Eupraxia clinical study’s monitoring.
Travel requirement: Must be willing to travel domestically and internationally (approximately 20-25%), as needed
Reports to: SVP of Clinical Operations
Salary Range: $115,000 - $145,000 annually depending on education and relevant experience.
...Are you passionate about clinical research and ready to make an impact on patients' lives? We're looking for a Clinical Research Associate (CRA) to join a fast-growing biotech company (... ...~3+ years of CRA or site monitoring experience. ~ Strong knowledge of ICH-GCP and...
...people globally. Job Description Overall Purpose and Objective of Position The Utilities Operator is responsible for monitoring and operating plant boilers including all auxiliary equipment, responding to equipment issues or alarms, works in a safe and...
Overview Dispute Arbitrator The Dispute Production Associate is responsible for analyzing and finalizing the dispute process in accordance with published Dispute Policies and Operation Regulations. A core focus is to mitigate risk through rigorous control execution...
...Ability to navigate the internet, use Microsoft Outlook, Word, and particularly Excel. Familiarity with service ticketing tools such as Zendesk is a plus~Must be organized and detail-oriented. Accuracy and follow-through are critical~Accurate typing...
...Are you ready to revolutionize sales from the comfort of your own home? We're seeking exceptional leaders to join our remote team and take charge of our customer experience revolution! The Opportunity As a Remote Sales Manager, you'll lead a team of dedicated professionals...